Stroke, Vol 17, 622-626, Copyright © 1986 by American Heart Association
P Petersen and J Godtfredsen
The incidence of embolic complications among 426 patients with initial
paroxysmal atrial fibrillation (PAF) was analysed. A distinct clustering of
emboli was seen at the time of onset of PAF. After transition to chronic
atrial fibrillation (CAF), which developed in 141 patients (33.1%), the
incidence of emboli was seen to rise to a new level several times higher
than the incidence level for patients with PAF. Also in this group a
distinct clustering of emboli was seen during the first year after
transition to CAF. On this background it is suggested that patients with
PAF may benefit from treatment with anti- arrhythmic agents in order to
prevent the development of CAF and that anticoagulants for stroke
prevention seems especially desirable in atrial fibrillation (AF) of recent
onset.
ARTICLES
Embolic complications in paroxysmal atrial fibrillation
This article has been cited by other articles:
 |
|
 |
|
  D. J. Wilber Pursuing sinus rhythm in patients with persistent atrial fibrillation: when is it too late? J. Am. Coll. Cardiol., August 25, 2009; 54(9): 796 - 798. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Albrecht, R. A.K. Kalil, L. Schuch, R. Abrahao, J. R. M. Sant'Anna, G. de Lima, and I. A. Nesralla Randomized study of surgical isolation of the pulmonary veins for correction of permanent atrial fibrillation associated with mitral valve disease. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 454 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Khoo and G. Y. H. Lip Acute Management of Atrial Fibrillation Chest, March 1, 2009; 135(3): 849 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nieuwlaat, T. Dinh, S. B. Olsson, A. J. Camm, A. Capucci, R. G. Tieleman, G. Y.H. Lip, H. J.G.M. Crijns, and on behalf of the Euro Heart Survey Investigators Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur. Heart J., April 1, 2008; 29(7): 915 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. van der Hooft, J. Heeringa, G. G. Brusselle, A. Hofman, J. C. M. Witteman, J. H. Kingma, M. C. J. M. Sturkenboom, and B. H. Ch. Stricker Corticosteroids and the risk of atrial fibrillation. Arch Intern Med, May 8, 2006; 166(9): 1016 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mehra, E. J. Benjamin, E. Shahar, D. J. Gottlieb, R. Nawabit, H. L. Kirchner, J. Sahadevan, and S. Redline Association of Nocturnal Arrhythmias with Sleep-disordered Breathing: The Sleep Heart Health Study Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 910 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Capucci, M. Santini, L. Padeletti, M. Gulizia, G. Botto, G. Boriani, R. Ricci, S. Favale, F. Zolezzi, N. Di Belardino, et al. Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1913 - 1920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. van der Hooft, J. Heeringa, G. van Herpen, J. A. Kors, J. H. Kingma, and B. H. Ch. Stricker Drug-induced atrial fibrillation J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2117 - 2124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Manasse, P.G. Colombo, A. Barbone, P. Braidotti, G. Bulfamante, M. Roincalli, and R. Gallotti Clinical histopathology and ultrastructural analysis of myocardium following microwave energy ablation Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 573 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.Y.H. Lip and F.L. L. S. Hee Paroxysmal atrial fibrillation QJM, December 1, 2001; 94(12): 665 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Hart, L. A. Pearce, R. M. Rothbart, J. H. McAnulty, R. W. Asinger, J. L. Halperin, and for the Stroke Prevention in Atrial Fibrillation I Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy J. Am. Coll. Cardiol., January 1, 2000; 35(1): 183 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Corrado, M. Santarone, S. Beretta, G. Tadeo, L.M. Tagliagambe, G. Foglia-Manzillo, M. Spata, E. Miglierina, F. Acquati, and M. Santarone Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: A single centre 8{middle dot}5-year experience Europace, January 1, 2000; 2(2): 119 - 126. [Abstract] [PDF]
|
|
|
|
 |
|
 M Gasparini, M Mantica, M Brignole, L Gianfranchi, C Menozzi, F Pizzetti, G Magenta, P Delise, A Proclemer, S Tognarin, et al. Thromboembolism after atrioventricular node ablation and pacing: long term follow up Heart, October 1, 1999; 82(4): 494 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Levy, M. Maarek, P. Coumel, L. Guize, J. Lekieffre, J.-L. Medvedowsky, and A. Sebaoun Characterization of Different Subsets of Atrial Fibrillation in General Practice in France : The ALFA Study Circulation, June 15, 1999; 99(23): 3028 - 3035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Eckman, R. H. Falk, and S. G. Pauker Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation Arch Intern Med, August 10, 1998; 158(15): 1669 - 1677. [Abstract] [Full Text]
|
|
|
|
|
|
A. P. Aboaf and P. S. Wolf Paroxysmal Atrial Fibrillation: A Common but Neglected Entity Arch Intern Med, February 26, 1996; 156(4): 362 - 367. [Abstract] [PDF]
|
|
|
|
 |
|
 H.-J. Lin, P. A. Wolf, E. J. Benjamin, A. J. Belanger, and R. B. D'Agostino Newly Diagnosed Atrial Fibrillation and Acute Stroke : The Framingham Study Stroke, September 1, 1995; 26(9): 1527 - 1530. [Abstract] [Full Text]
|
|
|
|
|
|
Atrial Fibrillation Investigators: Atrial Fibrilla, Boston Area Anticoagulation Trial for Atrial Fibri, Canadian Atrial Fibrillation Anticoagulation Study, Stroke Prevention in Atrial Fibrillation Study, and Veterans Affairs Stroke Prevention in Nonrheumatic Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation: Analysis of Pooled Data From Five Randomized Controlled Trials Arch Intern Med, July 11, 1994; 154(13): 1449 - 1457. [Abstract] [PDF]
|
|
|
|
 |
|
 D. C. Anderson How Twin Cities Neurologists Treat Ischemic Stroke: Policies and Trends Arch Neurol, October 1, 1993; 50(10): 1098 - 1103. [Abstract] [PDF]
|
|
|
|
 |
|
 W. J. Manning, D. I. Silverman, S. Gordon, H. M. Krumholz, and P. S. Douglas Cardioversion from Atrial Fibrillation without Prolonged Anticoagulation with Use of Transesophageal Echocardiography to Exclude the Presence of Atrial Thrombi N. Engl. J. Med., March 18, 1993; 328(11): 750 - 755. [Abstract] [Full Text]
|
|
|
|
|
|
M. Kutner, G. Nixon, and F. Silverstone Physicians' Attitudes Toward Oral Anticoagulants and Antiplatelet Agents for Stroke Prevention in Elderly Patients With Atrial Fibrillation Arch Intern Med, October 1, 1991; 151(10): 1950 - 1953. [Abstract] [PDF]
|
|
|
|
 |
|
 J. L Halperin Prevention of embolism in atrial fibrillation Vascular Medicine, September 1, 1991; 2(2): 111 - 119. [PDF]
|
|
|
|
|
|
J. E. Wipf and B. A. Lipsky Atrial Fibrillation Arch Intern Med, August 1, 1990; 150(8): 1598 - 1603. [Abstract] [PDF]
|
|
|
|
|
|
P. Petersen, J. Kastrup, S. Helweg-Larsen, G. Boysen, and J. Godtfredsen Risk Factors for Thromboembolic Complications in Chronic Atrial Fibrillation: The Copenhagen AFASAK Study Arch Intern Med, April 1, 1990; 150(4): 819 - 821. [Abstract] [PDF]
|
|
|
|
|
|
Cardiogenic Brain Embolism: The Second Report of the Cerebral Embolism Task Force Arch Neurol, July 1, 1989; 46(7): 727 - 743. [Abstract] [PDF]
|
|